What a pleasure to have hosted Dr. Joan Massague from MSKCC @mskcancercenter.bsky.social who visited us all day and delivered an exceptional lecture for our @einsteinmededu.bsky.social Montefiore Einstein Comprehensive Cancer Center distinguished lecture series. Thanks for visiting!

#ICYMI: 36 MSK researchers are among the @clarivateag.bsky.social list of Highly Cited Researchers 2025, which identifies scientists who have demonstrated significant and broad influence in their field(s) of research.

Experts at MSK are making strides in cancer care. New research uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative #breastcancer among Black women; and more.

A team at MSK is shedding new light on #VEXAS syndrome, a severe autoinflammatory condition arising from a mutation in the UBA1 gene. “We are hopeful that the therapeutic targets identified by our research can pave the way for new approaches.” says @gitlinlabmsk.bsky.social. bit.ly/4oRQ5LF

At #iwNHL25, Alexey Danilov of @cityofhope.bsky.social and Meghan Thompson of @mskcancercenter.bsky.social sat down to provide an update on BTK-targeting therapies in non-Hodgkin #lymphoma and CLL.🩸 This is a discussion you don't want to miss! Click here: 🎥 buff.ly/t3TZTiT #LYMsm #HemOnc

🚨Thrilled to share our latest work, published online today @nature.com in which we decipher mechanisms underlying the enigmatic VEXAS syndrome - a huge team effort @mskcancercenter.bsky.social led by superstars Varun Narendra + @tandriladas.bsky.social 1/ www.nature.com/articles/s41...

Congratulations to this year’s recipients of the MSK 2025 Paul Marks Prize for Cancer Research: Dr. @oawlab.bsky.social, of MSK; Dr. Andrea Ablasser, of EPFL; and Dr. Christina Curtis, of @stanfordmedicine.bsky.social. Learn more about the winners: bit.ly/47y8HLb

thanks to @mskcancercenter.bsky.social for sponsoring the SKI Basic Science Retreat, highlighting fundamental discoveries and forging new interactions amongst colleagues. our lab presented the next three papers we are writing up, ranging from miRNA biology, neural RBPs, to Hox TF grammar! 🔬🪰🧬

Eugene Pietzak, MD, of Memorial Sloan Kettering Cancer Center leads Alliance A032303/GAIN-BCG testing if the addition of the anti-cancer drug gemcitabine to the standard treatment of BCG immunotherapy helps patients whose bladder cancer has recurred. Learn more at https://bit.ly/Alliance-A032303.

Here, Dr. Pedram Razavi explains MSK's efforts to prevent drug resistance from developing in #breastcancer patients. A new study seeks to anticipate the malignant cells' next move, like playing poker with cancer and being able to see most of its cards. Learn more: bit.ly/47cxyDZ

Excited to announce a new publication from our @mskcancercenter.bsky.social Histiocytosis group identifying a predictor for impaired response to MEK inhibition in histiocytosis patients and potential for ERK inhibition. Out today in @Cancer_Cell. www.sciencedirect.com/science/arti...

MSK experts are investigating whether #brachytherapy may be an effective treatment option for reducing local recurrence, lowering the risk of #necrosis associated with standard #radiation, and improving the quality of life for patients with brain #metastases. Learn more ⬇️

We're excited to share that we've been recognized as #1 in oncology on @newsweek.com's World's Best Specialized Hospitals List. bit.ly/4nefIFv

#ESMO25 may be over, but #cancerresearch continues! Dr. Vicky Makker presented 5-year follow-up data from the 309/KEYNOTE-775 study that confirmed the efficacy and safety of lenvatinib plus pembrolizumab in advanced #endometrialcancer. @mskcancercenter.bsky.social ➡️ bit.ly/3JncnWA

We're excited to share that Dr. Omar Abdel-Wahab, a leukemia specialist at MSK, has been elected to the @nam.edu. With Dr. Abdel-Wahab’s appointment, a total of 28 MSK faculty members have been conferred with this recognition. Congratulations, Dr. Abdel-Wahab! bit.ly/49ezKw0

MSK researchers presented exciting advances in medical oncology for a range of cancer types at the @myesmo.bsky.social Congress 2025 held in Berlin. Highlights include the latest updates on phase 1 trials testing innovative treatment approaches for select patients w/ advanced solid tumors and more:

Tomorrow at #ESMO25, Violaine Randrian will present a study investigating whether the mechanism of mismatch repair protein loss impacts outcomes for those with solid tumors treated with #immunotherapy. @mskcancercenter.bsky.social Learn more: bit.ly/4neLsu1 🗓️ October 18 | 11:10 a.m. CEST

Don't miss the first presidential symposium at #ESMO25! Tomorrow, join @DrRosenbergMSK to hear his thoughts on a study of perioperative enfortumab vedotin plus pembrolizumab in participants with muscle-invasive #bladdercancer. @mskcancercenter.bsky.social Learn more: bit.ly/42JM3ws

Join us on November 12 (8:30–10:30 am) for new a complimentary series exploring how imagination, spirituality, and artistic expression serve as powerful resources in cancer care, featuring Will Schwalbe and Chef JJ Johnson: bit.ly/CreativeHeart2025 @mskcancercenter.bsky.social #MSKCreativeHeartCME

Tomorrow at #ESMO25, Dr. Vicky Makker will present at an education session about selecting the best first-line treatment based on molecular classification. @mskcancercenter.bsky.social @myesmo.bsky.social Learn more: bit.ly/3W6rqqz

Huge congratulations to @rosslevinemd.bsky.social, who has been named @mskcancercenter.bsky.social's new Chief Scientific Officer! We’re deeply grateful to have his expertise on our Board of Directors and as Chair of our Scientific Advisory Committee. www.mskcc.org/news-release...

Exciting news: Dr. Ross Levine, Senior Vice President of Translational Research at MSK, has been named MSK's new Chief Scientific Officer (CSO). Congratulations, Dr. Levine! bit.ly/4hfeWq7

When a routine prenatal screening revealed abnormal results, Dr. Sara Teichholtz turned to MSK. Her care team diagnosed her with a rare cancer and developed a treatment plan. Nearly three years later, she has no evidence of disease.

MSK researchers found that locoregional recurrence (LRR) rates were significantly lower for #breastcancer patients who completed at least one form of adjuvant therapy after #lumpectomy.

Thank you @mskcancercenter.bsky.social for highlighting our work on #viralmimicry in our genome, its evolution, the selective forces on it, and its potential role in cancer. A great years long collaborative effort with @petrsulc.bsky.social, @daniel-decarvalho.bsky.social, & many great colleagues!

MSK computer scientists and radiation oncologists have developed #AI models to make #radiation therapy safer and more effective — helping to spare healthy tissue and make decisions about needed changes to treatment faster. Learn more: bit.ly/3KE8tcl

Dr. @bengrbm.bsky.social has tried to shed light on the innate immune system and how it affects cancer cells as they evolve. Now Dr. Greenbaum’s lab has been taking a deep dive into modeling viral mimicry, trying to understand how this could shape cancer cells’ development process. bit.ly/3VWadA8

Congratulations to MSK's most recent Awards & Appointments honorees, including Dr. Maria Jasin for being awarded the 2025 Peral Meister Greengard Prize, MSK being named one of the World’s Best Specialized Hospitals by @newsweek.com, and more ⬇️

What a fantastic day of learning courtesy of @mskcme.bsky.social @mskcancercenter.bsky.social ! Can’t wait for tomorrow’s sessions! Thank you @billyrosaphd.bsky.social & your planning team 🎉!

New from MSK: A team co-led by Dr. Talya Salz and Dr. Thomas Atkinson are studying how an algorithm guided by a large language model could help identify themes related to the experience of #cancer pain from narrative reports. Learn more: www.mskcc.org/news/msk-res...

Big news! 🚀 I’m joining MSK as a Postdoctoral Fellow in the Balachandran Lab! 🔬I’ll focus on tumor immunology in pancreatic cancer—harnessing the immune system to advance future therapies. Looking forward to growing with MSK’s research community! @mskcancercenter.bsky.social

Krisstina Gowin and I discuss the importance of patient-centered wellness interventions in the field of hematology @ashclinicalnews.bsky.social @ash.hematology.org @mskcancercenter.bsky.social @cityofhope.bsky.social ashpublications.org/ashclinicaln... #mmsm #lymsm #bmtsm #leusm

MSK's Dr. Nancy Lee presented updated results at the Annual Meeting of @astro-org.bsky.social confirming that the addition of pembrolizumab to standard of care improved event-free survival for people with locally advanced #HNSCC. bit.ly/48LfqlI

At this year's @astro-org.bsky.social conference, MSK experts shared their work in more than 60 presentations & poster sessions. The presentations included two clinical trials that looked at the benefits & effects of lowering #radiation doses. Check out more highlights from the #ASTRO25 conference:

(1/2) Presented at #ASTRO25: Results from a MSK-led clinical trial show that #protonbeam radiotherapy resulted in similar oncologic outcomes w/ less toxicity and improved quality of life than #photonbeam radiotherapy (intensity modulated #radiotherapy, IMRT) in patients w/ head and neck cancers.

Coming up at #ASTRO25: MSK’s Dr. Nancy Lee will discuss #neoadjuvant and #adjuvant pembrolizumab plus standard of care in resectable locally advanced head and neck squamous cell #carcinoma. @astro-org.bsky.social Tuesday, 9/30 | 2:30 p.m. PDT Learn more: bit.ly/4pNSt7K

Cancer research saves lives. Dan Tukey is a survivor today thanks to the treatment he received in a colorectal cancer clinical trial funded by #StandUpToCancer. Help push cancer research further at StandUpToCancer.org. ❤️ @mskcancercenter.bsky.social

Undergoing chemotherapy doesn’t mean you have to lose your hair or identity. Honored to celebrate the passage of my first-in-the-nation law with Senator Stavisky requiring insurance carriers to cover the cost of scalp cooling at @mskcancercenter.bsky.social. 🎉

To all #MSKPostdocs - THANK YOU! Your contributions are vital to the @mskcancercenter.bsky.social research community. We are proud to celebrate you during #NPAW2025 and every day of the year! 👏🧪💙

MSK Kids, the pediatric cancer program at MSK, has one of the nation’s largest teams dedicated to neuroblastoma and treats more children w/ this cancer than any other center in the U.S. Learn more about the latest clinical & molecular research advances for patients w/ high-risk #neuroblastoma.

Rockstar #radonc @mskcancercenter.bsky.social resident Dr Kaitlyn Lapen presents at #ASTRO25 on quality of life improvements with early radiation for asymptomatic bone metastasis which may appear after 6 months. Optimal patient selection is key. @astro-org.bsky.social

Up next at #ASTRO25: MSK’s Dr. Alexander Goglia will discuss the impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Follow along for coverage of the latest advances. Monday, 9/29 | 10:45 a.m. PDT Learn more: bit.ly/483tNla

Up next at #ASTRO25: MSK’s Dr. Alexander Goglia will discuss the impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Follow along for coverage of the latest advances. Monday, 9/29 | 10:45 a.m. PDT Learn more: bit.ly/483tNla

Up next at #ASTRO25: MSK’s Dr. Alok Deshane will discuss TP53 mutations and outcomes after #radiotherapy in mantle cell #ymphoma. Follow along for coverage of the latest advances. Monday, 9/29 | 10:45 a.m. PDT Learn more: bit.ly/3W8iq43

Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️

Cancer research means bigger breakthroughs, on a faster timeline, that improve the lives of people impacted by cancer. Today is World Cancer Research Day & all donations will be DOUBLED. Donate today & help bring more possibilities to families facing cancer. bit.ly/46mefYy #WorldCancerResearchDay

ATG16L strikes again! New findings link #lysosome stress and physiology. Alison Klein and Michael Overholtzer @mskcancercenter.bsky.social discuss new study from @thabataduque.bsky.social et al. of the Deretic group (rupress.org/jcb/article/...) in Spotlight: rupress.org/jcb/article/...

🎥 At #SOHO2025, Ariela Noy of @mskcancercenter.bsky.social shared insights into the management of Burkitt #lymphoma, highlighting the need to improve frontline treatment. Watch here: 👉 buff.ly/kp1MrVH 👈 #LYMsm #Lymphoma #HemOnc #BloodSky #HemeSky #MedSky @societyofhemonc.bsky.social

Join us for MSK's 2025 Health Equity in Cancer Care Conference on Friday, November 14. This complimentary one-day event will unite experts from across fields, institutions, and specialties to explore actionable strategies for advancing #healthequity in underserved populations.

Coming up at #IMS25: Join MSK's Myeloma Service Chief @szusmani.bsky.social to learn about current challenges in #multiplemyeloma relapse & future research needed to overcome them. #mmsm 🗓️ Friday, September 19 | 9:40 a.m. EDT @mskcancercenter.bsky.social @myeloma-society.bsky.social